Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
105,052,618
-
Share change
-
+1,860,242
-
Total reported value
-
$4,254,138,314
-
Put/Call ratio
-
124%
-
Price per share
-
$40.50
-
Number of holders
-
301
-
Value change
-
+$23,536,743
-
Number of buys
-
150
-
Number of sells
-
132
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q1 2016
As of 31 Mar 2016 IONIS PHARMACEUTICALS INC - Common Stock (IONS) had 301 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 105,052,618 shares of stock of the company.
Largest 10 holders included FMR LLC, Clearbridge Investments, LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BB BIOTECH AG, WADDELL & REED FINANCIAL INC, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and FRANKLIN RESOURCES INC.
This table shows 301 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.